NasdaqCM - Delayed Quote USD

enGene Holdings Inc. (ENGN)

14.72 -0.03 (-0.20%)
At close: 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
10/31/2023
10/31/2022
10/31/2021
10/31/2020
Operating Expense
32,200.00
26,060.00
19,427.00
15,870.00
13,853.00
Operating Income
-32,200.00
-26,060.00
-19,427.00
-15,870.00
-13,853.00
Net Non Operating Interest Income Expense
-2,366.00
-3,836.00
-1,294.00
-4,999.00
-3,643.00
Other Income Expense
-68,657.00
-70,004.00
-3,719.00
-2,572.00
2,428.00
Pretax Income
-103,223.00
-99,900.00
-24,440.00
-23,441.00
-15,068.00
Tax Provision
-13.00
17.00
22.00
--
--
Net Income Common Stockholders
-106,798.00
-104,739.00
-29,024.00
-22,250.00
-16,645.00
Diluted NI Available to Com Stockholders
-106,798.00
-104,739.00
-29,024.00
-22,250.00
-16,645.00
Basic EPS
-4.60
-4.52
-1.25
-0.96
-0.72
Diluted EPS
-4.60
-4.52
-1.25
-0.96
-0.72
Basic Average Shares
23,197.98
23,197.98
23,197.98
23,197.98
23,197.98
Diluted Average Shares
23,197.98
23,197.98
23,197.98
23,197.98
23,197.98
Total Operating Income as Reported
-32,200.00
-26,060.00
-19,427.00
-15,870.00
-13,853.00
Total Expenses
32,200.00
26,060.00
19,427.00
15,870.00
13,853.00
Net Income from Continuing & Discontinued Operation
-103,210.00
-99,917.00
-24,462.00
-23,441.00
-15,068.00
Normalized Income
-90,674.58
-91,719.20
-22,206.24
-20,988.00
-17,561.00
Interest Income
1,975.00
1,117.00
129.00
25.00
56.00
Interest Expense
4,341.00
4,953.00
1,423.00
5,024.00
3,699.00
Net Interest Income
-2,366.00
-3,836.00
-1,294.00
-4,999.00
-3,643.00
EBIT
-98,882.00
-94,947.00
-23,017.00
-18,417.00
-11,369.00
EBITDA
-98,673.00
-94,772.00
-22,779.00
-18,145.00
-11,110.00
Reconciled Depreciation
209.00
175.00
238.00
272.00
259.00
Net Income from Continuing Operation Net Minority Interest
-103,210.00
-99,917.00
-24,462.00
-23,441.00
-15,068.00
Total Unusual Items Excluding Goodwill
-12,537.00
-13,663.00
-3,057.00
-2,453.00
2,493.00
Total Unusual Items
-12,537.00
-13,663.00
-3,057.00
-2,453.00
2,493.00
Normalized EBITDA
-86,136.00
-81,109.00
-19,722.00
-15,692.00
-13,603.00
Tax Rate for Calcs
0.00
0.00
0.00
--
--
Tax Effect of Unusual Items
-1.58
-5,465.20
-801.24
--
--
10/31/2020 - 2/1/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AVTE Aerovate Therapeutics, Inc.
21.57
+1.75%
 
NAMS NewAmsterdam Pharma Company N.V.
21.44
-1.65%
 
ELVN Enliven Therapeutics, Inc.
16.78
-4.06%
 
LRMR Larimar Therapeutics, Inc.
6.33
-2.01%
 
CGON CG Oncology, Inc.
36.20
+0.42%
 
KROS Keros Therapeutics, Inc.
54.19
-3.65%
 
DNTH Dianthus Therapeutics, Inc.
20.99
-1.55%
 
PHVS Pharvaris N.V.
22.77
+7.15%
 
TYRA Tyra Biosciences, Inc.
15.11
-5.56%
 
AGIO Agios Pharmaceuticals, Inc.
31.67
0.00%